• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在不断演变的高血压管理模式中使用单片复方制剂疗法。

Use of single-pill combination therapy in the evolving paradigm of hypertension management.

作者信息

Calhoun David A

出版信息

Expert Opin Pharmacother. 2009 Aug;10(12):1869-74. doi: 10.1517/14656560902980210.

DOI:10.1517/14656560902980210
PMID:19496740
Abstract

The use of antihypertensive therapy is an evolving paradigm. Although blood pressure (BP) control rates remain low, there have been improvements that may be attributable in part to a recent shift in clinical guidelines that recognizes that most patients will require multiple drugs to reach BP goals and encourages clinicians to use combination therapy as first-line treatment in selected patients. Single-pill combinations of two complementary antihypertensive medications offer benefits beyond those of separate administration of the individual component agents, providing a simpler medication regimen that is effective and well tolerated while enhancing patient adherence to therapy. In the future, there may be single-pill combinations of three antihypertensive drugs to further enhance BP control rates.

摘要

抗高血压治疗的应用是一个不断发展的模式。尽管血压(BP)控制率仍然较低,但已经有所改善,这部分可能归因于临床指南最近的转变,该转变认识到大多数患者需要多种药物才能达到血压目标,并鼓励临床医生在特定患者中使用联合治疗作为一线治疗。两种互补抗高血压药物的单片复方制剂提供了比单独使用各成分药物更多的益处,提供了一种更简单的药物治疗方案,既有效又耐受性良好,同时提高了患者对治疗的依从性。未来,可能会有三种抗高血压药物的单片复方制剂,以进一步提高血压控制率。

相似文献

1
Use of single-pill combination therapy in the evolving paradigm of hypertension management.在不断演变的高血压管理模式中使用单片复方制剂疗法。
Expert Opin Pharmacother. 2009 Aug;10(12):1869-74. doi: 10.1517/14656560902980210.
2
Improving blood pressure control rates by optimizing combination antihypertensive therapy.通过优化联合降压治疗提高血压控制率。
Expert Opin Pharmacother. 2010 Aug;11(12):2011-26. doi: 10.1517/14656566.2010.500614.
3
Optimizing management of hypertension with combination therapy: considerations for the nurse practitioner.联合治疗优化高血压管理:执业护士的考量因素
J Cardiovasc Nurs. 2009 Sep-Oct;24(5):380-9. doi: 10.1097/JCN.0b013e3181aed18e.
4
Issues in blood pressure control and the potential role of single-pill combination therapies.血压控制存在的问题及单片复方制剂治疗的潜在作用。
Int J Clin Pract. 2009 May;63(5):790-8. doi: 10.1111/j.1742-1241.2009.01999.x. Epub 2009 Feb 11.
5
Single-pill combination of amlodipine and valsartan in the management of hypertension.氨氯地平和缬沙坦单片复方制剂用于高血压治疗
Expert Opin Pharmacother. 2009 Aug;10(12):1979-94. doi: 10.1517/14656560903120899.
6
A role for single-pill triple therapy in hypertension.单片三联疗法在高血压治疗中的作用。
Ther Adv Cardiovasc Dis. 2009 Jun;3(3):231-40. doi: 10.1177/1753944709334947. Epub 2009 May 14.
7
Compliance with antihypertensive therapy: raising the bar of expectations.抗高血压治疗的依从性:提高期望标准。
Am J Manag Care. 1998 Jul;4(7):957-66.
8
International open-label studies to assess the efficacy and safety of single-pill amlodipine/atorvastatin in attaining blood pressure and lipid targets recommended by country-specific guidelines: the JEWEL programme.国际开放标签研究,以评估单片氨氯地平/阿托伐他汀在实现各国特定指南所推荐的血压和血脂目标方面的疗效和安全性:JEWEL计划。
Eur J Cardiovasc Prev Rehabil. 2009 Aug;16(4):472-80. doi: 10.1097/HJR.0b013e32832b63f5.
9
Fixed-dose triple-combination treatments in the management of hypertension.固定剂量三联组合疗法用于高血压管理
Manag Care. 2013 Dec;22(12):45-55.
10
Managing the patient with hard-to-control hypertension.管理难以控制的高血压患者。
Am Fam Physician. 1998 Mar 1;57(5):1007-14, 1019-20.

引用本文的文献

1
Small-Molecule Dual PLK1 and BRD4 Inhibitors are Active Against Preclinical Models of Pediatric Solid Tumors.小分子双靶点PLK1和BRD4抑制剂对儿童实体瘤临床前模型具有活性。
Transl Oncol. 2020 Feb;13(2):221-232. doi: 10.1016/j.tranon.2019.09.013. Epub 2019 Dec 21.
2
Combined olmesartan, amlodipine, and hydrochlorothiazide therapy in randomized patients with hypertension: a subgroup analysis of the TRINITY study by age.随机高血压患者中奥美沙坦、氨氯地平和氢氯噻嗪联合治疗:TRINITY 研究按年龄的亚组分析。
Drugs Aging. 2013 Jul;30(7):549-60. doi: 10.1007/s40266-013-0072-1.
3
Olmesartan/amlodipine/hydrochlorothiazide in participants with hypertension and diabetes, chronic kidney disease, or chronic cardiovascular disease: a subanalysis of the multicenter, randomized, double-blind, parallel-group TRINITY study.
奥美沙坦/氨氯地平/氢氯噻嗪在高血压合并糖尿病、慢性肾脏病或慢性心血管疾病患者中的应用:多中心、随机、双盲、平行分组 TRINITY 研究的亚组分析。
Cardiovasc Diabetol. 2012 Oct 30;11:134. doi: 10.1186/1475-2840-11-134.
4
Long-term efficacy and safety of triple-combination therapy with olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide for hypertension.奥美沙坦酯、苯磺酸氨氯地平与氢氯噻嗪三联治疗高血压的长期疗效和安全性。
J Clin Hypertens (Greenwich). 2012 Mar;14(3):149-57. doi: 10.1111/j.1751-7176.2011.00588.x. Epub 2012 Jan 24.
5
Role of olmesartan in combination therapy in blood pressure control and vascular function.奥美沙坦在联合治疗中对血压控制和血管功能的作用。
Vasc Health Risk Manag. 2010 Sep 7;6:701-9. doi: 10.2147/vhrm.s6663.